Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:EMX - CA26873J1075 - Common Stock

4.16 USD
+0.11 (+2.72%)
Last: 11/12/2025, 8:16:25 PM
4.07 USD
-0.09 (-2.16%)
After Hours: 11/12/2025, 8:16:25 PM
Fundamental Rating

5

Taking everything into account, EMX scores 5 out of 10 in our fundamental rating. EMX was compared to 156 industry peers in the Metals & Mining industry. While EMX has a great health rating, there are worries on its profitability. EMX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year EMX was profitable.
In the past year EMX had a positive cash flow from operations.
In the past 5 years EMX reported 4 times negative net income.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

EMX has a Return On Assets of 3.31%. This is in the better half of the industry: EMX outperforms 66.23% of its industry peers.
EMX has a Return On Equity of 4.19%. This is in the better half of the industry: EMX outperforms 62.99% of its industry peers.
EMX has a Return On Invested Capital (2.64%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROIC 2.64%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.31%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

Looking at the Profit Margin, with a value of 16.27%, EMX belongs to the top of the industry, outperforming 81.17% of the companies in the same industry.
EMX has a better Operating Margin (15.94%) than 70.78% of its industry peers.
Industry RankSector Rank
OM 15.94%
PM (TTM) 16.27%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

7

2. Health

2.1 Basic Checks

EMX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EMX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EMX has more shares outstanding
EMX has a worse debt/assets ratio than last year.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

EMX has an Altman-Z score of 12.53. This indicates that EMX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.53, EMX is in the better half of the industry, outperforming 79.87% of the companies in the same industry.
The Debt to FCF ratio of EMX is 9.09, which is on the high side as it means it would take EMX, 9.09 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EMX (9.09) is better than 61.04% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that EMX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.22, EMX perfoms like the industry average, outperforming 44.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 9.09
Altman-Z 12.53
ROIC/WACC0.3
WACC8.74%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

EMX has a Current Ratio of 7.95. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.95, EMX belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
EMX has a Quick Ratio of 7.95. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EMX (7.95) is better than 87.01% of its industry peers.
Industry RankSector Rank
Current Ratio 7.95
Quick Ratio 7.95
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 294.55% over the past year.
Looking at the last year, EMX shows a decrease in Revenue. The Revenue has decreased by -8.72% in the last year.
The Revenue has been growing by 40.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)294.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 71.00% on average per year.
EMX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.78% yearly.
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 104.00 indicates a quite expensive valuation of EMX.
The rest of the industry has a similar Price/Earnings ratio as EMX.
EMX is valuated expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
EMX is valuated quite expensively with a Price/Forward Earnings ratio of 94.81.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EMX is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of EMX to the average of the S&P500 Index (23.13), we can say EMX is valued expensively.
Industry RankSector Rank
PE 104
Fwd PE 94.81
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

EMX's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 232.63
EV/EBITDA 58.49
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

EMX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EMX's earnings are expected to grow with 71.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y71%

0

5. Dividend

5.1 Amount

EMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EMX ROYALTY CORP

NYSEARCA:EMX (11/12/2025, 8:16:25 PM)

After market: 4.07 -0.09 (-2.16%)

4.16

+0.11 (+2.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07
Earnings (Next)03-10 2026-03-10
Inst Owners22.14%
Inst Owner Change9.08%
Ins Owners14.94%
Ins Owner ChangeN/A
Market Cap454.19M
Revenue(TTM)29.86M
Net Income(TTM)4.86M
Analysts84.44
Price Target4.26 (2.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.51%
Min EPS beat(2)35.92%
Max EPS beat(2)197.09%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 104
Fwd PE 94.81
P/S 21.42
P/FCF 232.63
P/OCF 44.15
P/B 5.51
P/tB 5.51
EV/EBITDA 58.49
EPS(TTM)0.04
EY0.96%
EPS(NY)0.04
Fwd EY1.05%
FCF(TTM)0.02
FCFY0.43%
OCF(TTM)0.09
OCFY2.27%
SpS0.19
BVpS0.75
TBVpS0.75
PEG (NY)0.45
PEG (5Y)N/A
Graham Number0.82
Profitability
Industry RankSector Rank
ROA 3.31%
ROE 4.19%
ROCE 3.34%
ROIC 2.64%
ROICexc 3.17%
ROICexgc 3.17%
OM 15.94%
PM (TTM) 16.27%
GM N/A
FCFM 9.21%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 9.09
Debt/EBITDA 2.31
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.84
Cash Conversion 133.67%
Profit Quality 56.58%
Current Ratio 7.95
Quick Ratio 7.95
Altman-Z 12.53
F-Score7
WACC8.74%
ROIC/WACC0.3
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)294.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.19%
EPS Next Y233.33%
EPS Next 2Y100%
EPS Next 3Y71%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.72%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%4.05%
Revenue Next Year15.63%
Revenue Next 2Y9.51%
Revenue Next 3Y10.78%
Revenue Next 5YN/A
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3429.69%
EBIT Next 3Y256.52%
EBIT Next 5YN/A
FCF growth 1Y179.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y622.92%
OCF growth 3YN/A
OCF growth 5YN/A

EMX ROYALTY CORP / EMX FAQ

What is the fundamental rating for EMX stock?

ChartMill assigns a fundamental rating of 5 / 10 to EMX.


Can you provide the valuation status for EMX ROYALTY CORP?

ChartMill assigns a valuation rating of 3 / 10 to EMX ROYALTY CORP (EMX). This can be considered as Overvalued.


Can you provide the profitability details for EMX ROYALTY CORP?

EMX ROYALTY CORP (EMX) has a profitability rating of 3 / 10.


What is the financial health of EMX ROYALTY CORP (EMX) stock?

The financial health rating of EMX ROYALTY CORP (EMX) is 7 / 10.